Arxada Combines with Troy Corporation

Arxada AG Acquires Enviro Tech Chemical Services, Inc.

December 23, 2021

Manufacturing

Arxada AG, a Basel-based specialty chemicals company owned by Bain Capital and Cinven, completed the acquisition of Enviro Tech Chemical Services, Inc. on 22 December 2021. The deal adds Enviro Tech’s antimicrobial and biocidal platform (notably peracetic acid and bromine chemistries), three U.S. manufacturing sites, and expanded access to food & beverage, agriculture and wastewater treatment end markets; financial terms were not disclosed.

Pfizer's Hospital Business Acquires Arixa Pharmaceuticals

October 22, 2020

Pharmaceuticals

Pfizer’s Hospital Business acquired Arixa Pharmaceuticals to advance development of Arixa’s lead oral prodrug ARX-1796, a potential oral beta-lactamase inhibitor + antibiotic combination. Financial terms were not disclosed; Arixa was a virtual, asset-light company based in Palo Alto and was advised by Four Oaks Partners on the transaction.

Arkema Acquires ArrMaz from Golden Gate Capital

May 16, 2019

Manufacturing

French chemicals maker Arkema has agreed to acquire ArrMaz, a global specialty chemicals company headquartered in Mulberry, Florida, from private equity firm Golden Gate Capital for approximately $570 million. The deal (expected to close summer 2019) brings ArrMaz's specialty additives and geographic footprint into Arkema's portfolio to expand its capabilities and end-market exposure in mining, crop nutrients and asphalt paving.

ARCHIMED Acquires and Merges Symbio and Proinnovera to Form Symbio Proinnovera

November 17, 2023

Healthcare Services

ARCHIMED has acquired US-based Symbio and Germany-based Proinnovera in an all-equity deal and merged them to create Symbio Proinnovera, a specialized dermatology-focused CRO. The combined group will offer end-to-end dermatology consulting, formulation, testing and clinical research across North America and Europe, with founders rolling equity into the new platform and ARCHIMED-appointed operating partners joining the board to drive growth and further acquisitions.

Digital.ai (TPG-backed) Acquires Arxan Technologies

April 16, 2020

Cybersecurity

Arxan Technologies, a provider of application protection and mobile app security solutions, has been acquired and combined with CollabNet VersionOne and XebiaLabs to form the TPG-backed Digital.ai value stream platform. TA Associates sold its stake in Arxan as part of the combination; financial terms were not disclosed. The deal integrates Arxan’s application-security capabilities into Digital.ai’s DevOps/DevSecOps platform to deliver a unified intelligent value stream for enterprise customers.

Carlyle and PAI Partners Acquire Theramex from CVC Capital Partners

March 28, 2022

Pharmaceuticals

Global private equity firms Carlyle and PAI Partners have agreed to acquire Theramex, a London-based specialty pharmaceuticals company focused on women's health, from CVC Capital Partners VI. The new owners plan to accelerate Theramex's international expansion and broaden its women's health product suite to drive further organic and inorganic growth.